HSBC analyst Damayanti Kerai reiterated a Buy rating and INR1,625.00 price target on Aurobindo Pharma (ARBP:IN).The analyst comments: "The US ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE